Introduction to Shenzhen Neoimmune Co., Ltd


Shenzhen Neoimmune Co., Ltd is a platform provider that provides data and technology in the field of immunology precision medicine and has successively been recognized as a national high-tech enterprise, Shenzhen innovative small and medium-sized enterprise, and Shenzhen science and technology small and medium-sized enterprise.


Relying on immunomics NGS technology, Shenzhen Neoimmune Co., Ltd provides product solutions for the whole process of disease discovery, detection, monitoring, etc., and has long been rooted in the field of hematological tumors, mainly engaged in the detection and monitoring of acute leukemia, lymphoma, and other diseases. As a leading immunoomics technology platform company in China, in the past 10 years, Shenzhen Neoimmune Co., Ltd has accumulated the largest immunomics information of scientific research/clinical samples in China, providing data support for tumor TCR and effective antibody screening, as well as future immunological library products such as tumor early screening, companion diagnosis, and MRD monitoring. The founding team has published more than 30 high-level papers in immunoomics and applied for more than 20 patents.

"Quantifying immunity and escorting health" is the principle and purpose that Shenzhen Neoimmune Co., Ltd has always adhered to.

Contact Us

8/F, Block A, Hengtemei Building, No. 3 Ganli Road, Longgang District, Shenzhen; 402, Kelente R&D Building, Ganli Road, Longgang District, Shenzhen.

TEL: 0755-8453-4802

EMAIL

query@neoimmune.cn